Please login to the form below

Not currently logged in
Email:
Password:

Canbex hires former Lilly medical director

Alberto Lledó joins UK-based biotech

Dr Alberto Lledó has joined Canbex Therapeutics as chief medical officer.

Dr Lledó is currently a senior consultant neurologist at Clínica Creu Blanca in Barcelona, Spain, although has pharma experience that includes 16 years at Lilly from 1995 to 2011.

During his time at Lilly he served in several senior positions, including global senior medical adviser and CNS clinical research physician for Europe, and helped co-ordinate phase II clinical trials for the company's neurology pipeline.

As chief medical officer at Canbex Dr Lledó will lead preparations for proof of concept trials for the company's lead candidate VSN16R, an oral drug intended for the treatment of spasticity in people with multiple sclerosis.

"I am delighted to be joining Canbex at such an important time in the development of VSN16R," Dr Lledó said. "As a practicing neurologist and experienced drug developer, I am very pleased to be addressing a serious need among people with multiple sclerosis for improved treatment of their spasticity.”

4th March 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics